» Articles » PMID: 17353886

Prevalence of Peripheral Arterial Disease and Prior Stroke in Octogenarians with Symptomatic Severe Aortic Stenosis or Severe Coronary Artery Disease: Influence in Management and Outcome

Overview
Journal Int Angiol
Publisher Minerva Medica
Date 2007 Mar 14
PMID 17353886
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Severe aortic stenosis (SAS) and severe coronary artery disease (SCAD) are the most frequent reasons to perform cardiac surgery in octogenarians. Non-coronary vascular disease is frequently present in these patients.

Methods: We assessed the prevalence and impact of previous stroke (PS) and peripheral arterial disease (PAD) on the management and outcome of 130 consecutive symptomatic patients (80 years old with SAS or SCAD.

Results: Mean age was 82.8+/-3.1 years. PS was present in 24 patients (18.5%) and PAD in 15 (11.5%). We found a non-significant trend to a higher prevalence of PAD in patients with SCAD than in patients with SAS (14.5% vs 6.4%, P=0.13), while no relevant differences were seen for PS prevalence (19.3% vs 17%, P=0.75). Patients with PS tended to be operated less frequently than patients without PS (20.8% vs 37.7%, P=0.08), while no relevant differences were seen for patients with and without PAD (26.7% vs 35.7%, P=0.5). Thirty-nine patients (30%) died during follow-up, mean of 1.1(0.7 years (median 1 years; 100% complete). There was a trend to a worse prognosis in patients with PAD (adjusted hazard ratio [HR] 2.2; 95% confidence interval [CI] 0.96-4.8; P=0.06), while PS showed no independent influence on survival (adjusted HR 1.3, 95% CI 0.6-2.8, P=0.53).

Conclusions: PS and PAD are frequently present in octogenarians with SAS or SCAD. Patients with PS show a similar long-term mortality, but tend to be operated less frequently. On the other hand, PAD did not influence the decision of surgical treatment, but is associated with a lower survival rate.

Citing Articles

Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.

Ogami T, Kurlansky P, Takayama H, Ning Y, Ali Z, Nazif T J Am Heart Assoc. 2021; 10(16):e019930.

PMID: 34387093 PMC: 8475055. DOI: 10.1161/JAHA.120.019930.


Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.

Zilberszac R, Chandiramani R, Hengstenberg C, Sartori S, Cao D, Chandrasekhar J Catheter Cardiovasc Interv. 2019; 96(3):E377-E386.

PMID: 31808295 PMC: 7540270. DOI: 10.1002/ccd.28642.


Clinical Arterial Peripheral Vascular Pathology Does Not Impact Short- or Long-Term Survival after Transcatheter Aortic Valve Replacement.

Klinkhammer B Int J Vasc Med. 2018; 2018:2707421.

PMID: 30112212 PMC: 6077653. DOI: 10.1155/2018/2707421.